Tradercommunity Clickoptions Forum

[Newsagent]

PR inside: INVESTOR ALERT: Pomerantz Law Firm Investigates ClaimsOn Behalf of ...

(PR-inside.com) NEW YORK, NY / ACCESS Newswire / July 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Jasper Therapeutics, Inc. ("Jasper" or the "Company") (NASDAQ:JSPR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

The investigation concerns whether Jasper and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here for information about joining the class action]

On July 7, 2025, Jasper issued a press release "reporting updated data from Company's BEACON Phase 1b/2a study of subcutaneous briquilimab in adult participants with CSU and providing an ..

https://reports.pr-inside.com/investor- ... 118736.htm
Copyright PR-Inside.com 2025